Incannex Healthcare
IXHL | NASDAQ
$1.93
-$0.04 (-2.03%)
At close: Nov 16, 2026, 4:00 PM ET
$1.93
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-2.03%
(1D)No price chart data available for 1D timeframe.
Rating
23.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #962/1021 (Top 94%)
Key Statistics
Market Data
Market Cap $23.09M
1D Range
1.90 2.01
52W Range
1.90 14.36
Valuation (TTM)
PE -2.88
PB 0.35
EV/EBITDA 2.27
Valuation (NTM)
Forward PE 32.44
Forward PEG -0.09
Price Target $0.00
Cash Flow
FCF Yield 6.2%
SBC Adj. FCF Yield -6.6%
SBC Impact -206.4%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -117.4% |
-57.2%
Dil EPS 3Y | 5Y 81.1% |
-5.2%
FCF 3Y | 5Y 115.7% |
9.9%
Returns
ROA -11.8%
ROE -12.4%
ROIC -18.2%
Financial Health
Net Cash
$68.18M
Current Ratio 67.79
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid c...
Sector Healthcare
Industry Biotechnology
Employees 12
IPO Date Mar 2, 2022
Website www.incannex.com
Fiscal Year July - June
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove IXHL